Fresh Tracks Therapeutics Inc (NASDAQ:FRTX)
| 0.83 Delayed Data As of Nov 30 |  -0.0249 / -2.95%Today’s Change | 0.45 Today|||52-Week Range 3.14 | -44.67% Year-to-Date |
Latest FRTX News | Press Releases
No recent news for Fresh Tracks Therapeutics Inc.
Today’s Trading
| Previous close | 0.85 |
| Today’s open | 0.84 |
| Day’s range | 0.82 - 0.85 |
| Volume | 20,247 |
| Average volume (3 months) | 238,962 |
| Market cap | $5.0M |
Data as of 3:53pm ET, 11/30/2023
Growth & Valuation
| Earnings growth (last year) | +66.02% |
| Earnings growth (this year) | +27.16% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1,618.56% |
| P/E ratio | NM |
| Price/Sales | 0.61 |
| Price/Book | 0.35 |
Competitors
| ---- | ||
| --GP Solutions Inc | 0.00 | 0.00% |
| HOTHHoth Therapeutics In... | +0.04 | +3.57% |
| AGRXAgile Therapeutics I... | +0.05 | +2.37% |
Data as of 3:59pm ET, 12/01/2023
Financials
| Next reporting date | March 20, 2024 |
| EPS forecast (this quarter) | -$1.51 |
| Annual revenue (last year) | $6.9M |
| Annual profit (last year) | -$21.1M |
| Net profit margin | -303.93% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
